Atlas Trials

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

Clinical trial NCT00804401 · COMPLETED

Trial details

NCT number
NCT00804401
Sponsor
Perrigo Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalency
Start date
2004-06-01
Primary completion
2004-07-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.